Chemours Reports Q1 Adj. EPS $0.05, $1.39B Revenue; Guides Q2 Sales Up 15-20%
CC has more than doubled off its 52-week low of $9.13 on elevated volume (2.0× avg).
Summary
The Chemours Company reported Q1 adjusted EPS of $0.05 on $1.39 billion in revenue, with its APM segment contributing $243 million in sales. The company incurred $25 million in outage costs related to the Washington Works outage and SPS Capstone line closure. This report provides additional detail to the Q1 2026 GAAP net loss of $(29) million and diluted loss per share of $(0.19) that was previously disclosed in an 8-K and news release yesterday. Crucially, Chemours also issued forward guidance, projecting Q2 sales to increase by 15-20% sequentially and full-year 2026 sales to grow by 3-5%. This guidance is a significant new piece of information for traders, offering insight into management's outlook. Investors will closely monitor the company's ability to meet these projections and manage operational costs.
At the time of this announcement, CC was trading at $23.67 on NYSE in the Manufacturing sector, with a market capitalization of approximately $3.6B. The 52-week trading range was $9.13 to $28.67. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Wiseek News.